1E Therapeutics

Drug development company creating first-in-class RNA-targeting therapeutics based on a proprietary drug design platform.

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
1E Therapeutics
02/07/2022
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Biochemical: non-pharmacological (RNA microchips, neurological scaffolding)
01/01/2020
"51-200"

1E Therapeutics is a breakthrough, drug development company creating RNA-targeting therapeutics based on a proprietary drug design platform.